IMPEDIMED LIMITED (IPD)
AI Coverate Rating: Moderate
ASX AI Signals has generated 2 signal(s) for IPD during the last 90 days,
indicating Moderate trading activity
Last signal: BUY on 26/05/2026
Current Price: $0.007
52 Week High: $0.057
52 Week Low: $0.006
Trading at 12.28% of its 52-week high
Unlock All ASX AI Signals
Get access to daily BUY & SELL signals,
advanced AI analysis, watchlists and email alerts.
14 Day Free Trial •
Cancel Anytime •
Founders Price $15/month
Start My Free Trial
Business Overview
Impedimed Limited (ASX: IPD) develops and markets bioimpedance measurement devices used for the detection and monitoring of lymphatic system disorders. Their technology helps healthcare professionals manage conditions such as lymphedema by providing accurate, non-invasive assessments. The company serves medical markets worldwide with a focus on improving patient outcomes.
Latest IMPEDIMED LIMITED(IPD) News
08 Apr 2026, 06:29 AM
Former Hologic executive to lead next phase of growth
and commercial execution for medical technology leader
CARLSBAD, Calif., April 7, 2026 /PRNewswire/ --Â ImpediMed, a leader in the development and commercialization of medical technologies to clinically monitor and manage fluid and body composi
Unlock All ASX AI Signals
Get access to daily BUY & SELL signals,
advanced AI analysis, watchlists and email alerts.
14 Day Free Trial •
Cancel Anytime •
Founders Price $15/month
Start My Free Trial